Second episode of our podcast has been published
08.04.2022
In the second episode Henrike has a chat with our colleague Oliver Wenske
08.04.2022
In the second episode Henrike has a chat with our colleague Oliver Wenske
01.04.2022
The Journal of Clinical Medicine published an article on 7 patients with severe COVID-19 who have been treated with CRP apheresis.
01.04.2022
Today the north-eastern German journal reports on C-reactive protein
06.04.2022
The event series of Brandenburg College For Nephrology starts of with the topic of CRP-Apheresis.
28.03.2022
A German medical magazine for intensive care and emergency medicine published a review on CRP-Apheresis in patients with acute myocardial infarction and COVID-19
28.03.2022
The Journal of Clinical Medicine published an article on the pros and cons of selective CRP-Apheresis in humans.
26.02.2022
The clinical observations of the article by Fabrizio Esposito, Harald Matthes and Friedemann Schad from the Havelhöhe Community Hospital in Berlin support the hypothesis that CRP is a possible therapeutic target in the treatment of early stages of severe COVID-19.
17.02.2022
A recently published article in the Journal of Clinical Medicine shows the influence of high levels of CRP on G-protein coupled receptors (GPCRs).
18.02.2022
The German magazine Superillu published an interview with an AMI patient who was treated with CRP apheresis and his physician.
20.01.22
At the web seminar "Biotech vs. SARS-CoV-2: A BioBilanz", Pentracor gave a lecture on CRP apheresis against COVID-19. The field report was presented by Managing Director Dr. Ahmed Sheriff.